2.
counterpulsation. Heart 1999;82:96-100.
Ferguson JJ, Cohen M, Freedman RJ Jr, Stone GW, Miller MF, Joseph DL et al.
The current practice of intra-aortic balloon counterpulsation: results from the
Benchmark Registry. J Am Coll Cardiol. 2001;38(5):1456-62.BIBLIOGRAFIA
Aksnes J, Abdelnoor M, Berge V, Fjeld NB. Risk factors of septicemia and perioperative
myocardial infarction in a cohort of patients supported with intra-aortic balloon pump
(IABP) in the course of open heart surgery. Eur J Cardiothorac Surg. 1993;7:153.
Alderman JD, Gabliani GI, McCabe CH et al. Incidence and management of limb
ischemia with percutaneous wire-guided intra-aortic balloon catheters. J Am Coll
Cardiol. 1987;9:524.
Anderson RD, Ohman EM, Holmes DR Jr et al. Use of intra-aortic balloon
counterpulsation in patients presenting with cardiogenic shock: observations from
the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded
Coronary Arteries. J Am Coll Cardiol. 1997;30:708.
Aru GM, King JT Jr, Hovaguimian H et al. The entrapped balloon: report of a possibly
serious complication. J Thorac Cardiovasc Surg. 1986;91:146.
Extracorporeal Life Support Orzanization (ELSO). Haft J, Bartlett R. Extracorporeal
membrane oxygenation (ECMO) in adults. ELSO guidelines for ECMO centers
(updated February 2005) http://www.elso.med.umich.edu/guide.htm (Acesso em 19
jun 2007).
Hill JG, Bruhn PS, Cohen SE et al. Emergent applications of cardiopulmonary support: a
multiinstitutional experience. Ann Thorac Surg. 1992;54:699.
Hyman BT, Landas SK, Ashman RF et al. Warfarin-related purple toes syndrome and
cholesterol microembolization. Am J Med. 1987;82:1233.
Ishihara M, Sato H, Tateishi H, Uchida T, Dote K. Intra-aortic balloon pumping as the
postangioplasty strategy in acute myocardial infarction. Am Heart J.
1991;122(2):385-9.
Jurmann MJ, Siniawski H, Erb M et al. Initial experience with miniature axial flow
ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;
77:1642.
Kar B, Gregoric ID, Basra SS et al. The percutaneous ventricular assist device in severe
refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688.
Kato S, Morimoto S, Hiramitsu S et al. Use of percutaneous cardiopulmonary support of
patients with fulminant myocarditis and cardiogenic shock for improving prognosis.
Am J Cardiol. 1999;83:623.